Video

The Impact of PCSK9 Inhibitors on Specialty Pharmacy

Author(s):

Lauren Santye, Assistant Editor

Daniel P. Kus, BS Pharm, RPh, vice president of Pharmacy Advantage, discusses the cost implications of pricey cholesterol-lowering PCSK9 inhibitors.

Daniel P. Kus, BS Pharm, RPh, vice president of Pharmacy Advantage, discusses the cost implications of pricey cholesterol-lowering PCSK9 inhibitors.

Related Videos
California Wildfires, Pharmacies, Community | image Credit: J Bettencourt/peopleimages.com | stock.adobe.com
California Wildfire, Pharmacy, Community | Image Credit: Erin | stock.adobe.com
Allergies, Asthma, Biologic Treatment, Pharmacists | Image Credit: Pixel-Shot | stock.adobe.com
Related Content
Investigational semaglutide dosage reduces weight loss by 20.7%. | Image Credit: alones | stock.adobe.com
January 23rd 2025

Investigational Dose of Semaglutide Shows 20.7% Weight Loss at 72 Weeks

Ashley Gallagher, Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

IV drip -- Image credit: sudok1 | stock.adobe.com
January 22nd 2025

Cost Avoidance and Satisfaction Associated With Clinical Pharmacy Services in a Veterans Affairs Specialty Clinic

Miranda Beaudoin Rampone, PharmD, MSCS, CSP Bryce A. Edwards, PharmD, RPh Allison Spaulding, PharmD Leslie Ochs, PharmD, PhD, BCPS
Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer
October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

Genetic Hemophilia Testing: Blood Sample Analysis for Inherited Condition
January 21st 2025

Proper Dosing, Bleeding Awareness Essential Roles of Pharmacists for Hemophila A and B, Thombocytopenic Purpura Treatment

Luke Halpern, Assistant Editor
GLP-1, Diabetes, Type 2 Diabetes | Image Credit: © neirfy | stock.adobe.com
January 20th 2025

ASHP Midyear: Expert Discusses GLP-1 Medications and Incretin Mimetics for Diabetes Care

Ashley Gallagher, Editor